On Thursday, April 12 an FDA advisory panel will discuss whether or not to recommend that the FDA approve Merck & Co’s... Read more »
On April 12th, a Food and Drug Administration, FDA, advisory panel of experts rejected Merck’s drug, Arcoxia, in a 20-1 vote. It is a... Read more »
On November 13th, the Associated Press released an article showing mixed reviews of Arcoxia, the cox-2 inhibitor drug that Merck is hoping... Read more »
Full Question: I've been told that Almonds are somehow comparable to aspirin or other forms like Tylenol or Advil is this true? Sheryl. ... Read more »
Full Question: I have been having migraine headaches for the past year. The pain starts in the back of my head on the left side and... Read more »
An advisory panel to the U.S. Food and Drug Administration has found mixed results about the safety of the new COX-2 inhibitor Arcoxia. In a recent... Read more »
This is a study to assess different doses of Arcoxia/MK-0663 in the treatment of patients with rheumatoid arthritis. This national study is currently... Read more »
A new study on the COX-2 inhibitor Arcoxia is intensifying worries about the drug's safety. Though researchers found that the new drug had similar... Read more »
The U.S. Food and Drug Administration (FDA) has rejected drugmaker Merck's request to sell the COX-2 inhibitor Arcoxia in the United States. Arcoxia... Read more »
A panel of experts that advises the U.S. Food and Drug Administration (FDA) has recommended that the new COX-2 inhibitor Arcoxia should not be... Read more »